AU4801000A - Nucleic acid vaccines against rickettsial diseases and methods of use - Google Patents
Nucleic acid vaccines against rickettsial diseases and methods of useInfo
- Publication number
- AU4801000A AU4801000A AU48010/00A AU4801000A AU4801000A AU 4801000 A AU4801000 A AU 4801000A AU 48010/00 A AU48010/00 A AU 48010/00A AU 4801000 A AU4801000 A AU 4801000A AU 4801000 A AU4801000 A AU 4801000A
- Authority
- AU
- Australia
- Prior art keywords
- methods
- nucleic acid
- vaccines against
- acid vaccines
- rickettsial diseases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 108700001237 Nucleic Acid-Based Vaccines Proteins 0.000 title 1
- 208000034712 Rickettsia Infections Diseases 0.000 title 1
- 229940023146 nucleic acid vaccine Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/29—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Richettsiales (O)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13072599P | 1999-04-22 | 1999-04-22 | |
US60130725 | 1999-04-22 | ||
PCT/US2000/010886 WO2000065063A2 (en) | 1999-04-22 | 2000-04-21 | Nucleic acid vaccines against rickettsial diseases and methods of use |
Publications (1)
Publication Number | Publication Date |
---|---|
AU4801000A true AU4801000A (en) | 2000-11-10 |
Family
ID=22446029
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU48010/00A Abandoned AU4801000A (en) | 1999-04-22 | 2000-04-21 | Nucleic acid vaccines against rickettsial diseases and methods of use |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1171606A2 (en) |
AU (1) | AU4801000A (en) |
WO (1) | WO2000065063A2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030044422A1 (en) * | 2001-02-20 | 2003-03-06 | Barbet Anthony F. | Ehrlichia ruminantium polypeptides, antigens, polynucleotides, and methods of use |
NZ532634A (en) | 2001-11-01 | 2006-09-29 | Res Dev Foundation | DNA encoding disulfide bond formation (Dsb) proteins from bacterial species of the genus Ehrlichia, such as Ehrlichia chaffeensis and Ehrlichia canis disulfide bond formation proteins. |
US7304139B2 (en) | 2003-10-28 | 2007-12-04 | University Of Florida Research Foundation, Inc. | Polynucleotides and polypeptides of Anaplasma phagocytophilum and methods of using the same |
RU2595427C2 (en) * | 2015-09-11 | 2016-08-27 | Федеральное государственное бюджетное научное учреждение "Центр экспериментальной эмбриологии и репродуктивных биотехнологий" (ФГБНУ ЦЭЭРБ) | SYNTHETIC OLIGODEOXYRIBONUCLEOTIDES FOR DETECTION OF msp4 GENE OF Anaplasma marginale RICKETTSIAE BY POLYMERASE CHAIN REACTION IN "REAL TIME" |
AU2023224276A1 (en) * | 2022-02-24 | 2024-08-22 | Kansas State University Research Foundation | Anaplasma vaccines and methods of use thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6025338A (en) * | 1996-10-17 | 2000-02-15 | University Of Florida | Nucleic acid vaccines against rickettsial diseases and methods of use |
-
2000
- 2000-04-21 WO PCT/US2000/010886 patent/WO2000065063A2/en active Application Filing
- 2000-04-21 AU AU48010/00A patent/AU4801000A/en not_active Abandoned
- 2000-04-21 EP EP00930134A patent/EP1171606A2/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
WO2000065063A9 (en) | 2002-02-14 |
WO2000065063A3 (en) | 2001-04-12 |
EP1171606A2 (en) | 2002-01-16 |
WO2000065063A2 (en) | 2000-11-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4913097A (en) | Nucleic acid vaccines against rickettsial diseases and methods of use | |
AU4520801A (en) | Novel substituted phenanthridinones and methods of use thereof | |
EP1578954A4 (en) | 5' cpg nucleic acids and methods of use | |
AU2003235707A1 (en) | Immunogenic preparations and vaccines on the basis of mrna | |
AU2001265346A1 (en) | Artificial antigen presenting cells and methods of use thereof | |
AU2002230831A1 (en) | Compositions of human proteins and method of use thereof | |
AU7339800A (en) | Ophthalmic device and method of manufacture and use | |
AU2072201A (en) | Agents and methods for the treatment of proliferative diseases | |
AU2001241918A1 (en) | Methods of enhancing activity of vaccines and vaccine compositions | |
AU6340600A (en) | Telomerase inhibitors and methods of their use | |
AU7748000A (en) | Method and composition for the treatment of dermatologic diseases | |
AU2002225954A1 (en) | Dipeptidylpeptidases and methods of use | |
AU3622600A (en) | Metalloproteinases and methods of use therefor | |
AU2002246808A1 (en) | Human nucleic acids and polypeptides and methods of use thereof | |
IL144845A0 (en) | Vaccines and gene therapy compositions and methods of making and using the same | |
AU2001240674A1 (en) | Dihydropyrimidine-5-carboxylic acid esters and use thereof as medicaments against viral diseases | |
AU2001292667A1 (en) | Immunogenic composition of hepatitis c and methods of use thereof | |
AU4801000A (en) | Nucleic acid vaccines against rickettsial diseases and methods of use | |
AU5428700A (en) | Acrylic acid derivatives, use of the same and intermediates for the preparation thereof | |
AU4014700A (en) | Tuberculosis antigens and methods of use therefor | |
AU3501700A (en) | Human endokine alpha and methods of use | |
AU4471700A (en) | Antisense human fucosyltransferase sequences and methods of use thereof | |
AU2001217686A1 (en) | Method of establishing cultures of human dendritic cells and use thereof | |
AU3356000A (en) | L-arginine based formulations for treating diseases and methods of using same | |
AU2001264824A1 (en) | Vaccine and gene therapy vector and methods of use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |